Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients

April N. Tucker, Katherine A. Tkaczuk, Lynn M. Lewis, Dragana Tomic, Chang K. Lim, Jodi A. Flaws

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences